Product Information
INPEFA 200 MG TABLET is a brand product labeled by Lexicon Pharmaceuticals, Inc., priced at $19.7358 per EA under NDC 70183022030. Its NADAC has been published 51 times since Apr 17, 2024.
Strength
200 mg/1
Manufacturer
Lexicon Pharmaceuticals, Inc.NDC
70183022030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
3/19/2025
Active Ingredients
SOTAGLIFLOZINApproval Type
New Drug (NDA)
FDA Application
NDA216203On Market Since
5/26/2023
Pharmacological Classes
Price Statistics
The NADAC for INPEFA 200 MG TABLET has been published 51 times since Apr 17, 2024, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.7358 per EA |
|---|---|
| All-time high | $19.7477 (Nov 13, 2024) |
| All-time low | $19.1726 (Apr 17, 2024) |
| Median price | $19.7345 |
| Average price | $19.6022 |
| Largest weekly change | +3.0% (Jul 10, 2024) |
| Weeks tracked | 51 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INPEFA 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INPEFA 200 MG TABLET, manufactured by Lexicon Pharmaceuticals, Inc., is $19.7358 per EA (NDC 70183022030), effective Apr 2, 2025.
How has the price of INPEFA 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for INPEFA 200 MG TABLET has risen 2.9%. It has been tracked across 51 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for INPEFA 200 MG TABLET?
Since Apr 17, 2024, the NADAC for INPEFA 200 MG TABLET has ranged from a low of $19.1726 (Apr 17, 2024) to a high of $19.7477 (Nov 13, 2024), with a median of $19.7345 per EA.
Are there cheaper alternatives to INPEFA 200 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as INPEFA 200 MG TABLET, but none are currently priced below it.
Who manufactures INPEFA 200 MG TABLET?
INPEFA 200 MG TABLET (NDC 70183022030) is labeled by Lexicon Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification